Loading data
IRDMNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 871.66 m USD | 830.68 m USD | 790.72 m USD | 721.03 m USD | 614.5 m USD |
| Research and development expense | 19.76 m USD | 28.42 m USD | 20.27 m USD | 16.22 m USD | 11.89 m USD |
| Selling, general and administrative expense | 157.71 m USD | 168.18 m USD | 143.71 m USD | 123.5 m USD | 100.47 m USD |
| Operating profit | 235.98 m USD | 200.38 m USD | 81.63 m USD | 76.68 m USD | 46.31 m USD |
| Interest expense | 14.7 m USD | 14.7 m USD | 14.7 m USD | — | — |
| Profit before tax | 144.81 m USD | 109.78 m USD | -4.75 m USD | 10.51 m USD | -28.89 m USD |
| Income tax expense | 27.62 m USD | 12.26 m USD | -26.25 m USD | 292 k USD | -19.57 m USD |
| Net income (reported basis) | 114.37 k USD | 112.78 k USD | 15.42 k USD | 8.72 k USD | -9.32 k USD |
| Net income attributable to common shareholders | 114.37 m USD | 112.78 m USD | 15.42 m USD | 8.72 m USD | -9.32 m USD |
| Basic earnings per share | 1.07 USD/share | 0.95 USD/share | 0.12 USD/share | 0.07 USD/share | -0.07 USD/share |
| Diluted earnings per share | 1.06 USD/share | 0.94 USD/share | 0.12 USD/share | 0.07 USD/share | — |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.